Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Telormedix logo — Pioneering targeted immunity for cancer and autoimmune disea...

Telormedix

Pioneering targeted immunity for cancer and autoimmune disease treatment through innovative biopharma solutions

Founded 2007 Series B Total: $31.16M Biopharma, Biotechnology +2

General Information

Company Name Telormedix
Founded Year 2007
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Telormedix. To contact Telormedix, visit telormedix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Telormedix

Telormedix is a biopharmaceutical company founded in 2007, with a focus on targeted immunity and the role of the innate immune system in treating cancer and autoimmune diseases. The company's slogan, "Pioneering targeted immunity for cancer and autoimmune disease treatment through innovative biopharma solutions," reflects its dedication to innovative biopharma solutions. Telormedix secured a notable €6.16M Series B investment on 02 December 2013, with funding from ProQuest Investments and Aravis. Telormedix operates within the Biopharma, Biotechnology, Health Care, and Health and Wellness industries.

Taxonomy: Biopharmaceutical, Innovative solutions, Targeted immunity, Cancer treatment, Autoimmune disease treatment, Biopharma, Innate immune system, Immunotherapy, Medical research, Drug development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €6.16M 2
ProQuest Investments Aravis
ProQuest Investments, Aravis
02 Dec 2013
Series B Fr.6.00M 2
ProQuest Investments Aravis
ProQuest Investments, Aravis
25 Jan 2012
Series A $19.00M 4
ProQuest Investments Aravis Nextech Invest
ProQuest Investments, Aravis +2
30 Sep 2008

Telormedix Alternatives & Competitors

View All Alternatives
Telormedix vs
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG Switzerland

Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific role in inn...

Series B
15 employees
Biotechnology, Health Care
Telormedix vs
Tallac Therapeutics
Tallac Therapeutics United States

Next generation immunotherapies for cancer patients: harnessing the power of innate and adaptive imm...

Debt Financing
18 employees
Biotechnology, Health Care
Telormedix vs
Biond Biologics Ltd
Biond Biologics Ltd Israel

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the tre...

Series C
43 employees
Biotechnology, Health Care
View all alternatives

FAQ About Telormedix

Pioneering targeted immunity for cancer and autoimmune disease treatment through innovative biopharma solutions
Telormedix was founded in 2007.
Telormedix operates in Biopharma, Biotechnology, Health Care and Health and Wellness. Its work centres on Biopharmaceutical, Innovative solutions, Targeted immunity and Cancer treatment.
Telormedix has completed 3 funding rounds, raising a total of $31.16M. The latest funding stage is Series B.
Top alternatives and competitors to Telormedix include ImmunOs Therapeutics AG, Tallac Therapeutics, Biond Biologics Ltd, Alvine Pharmaceuticals, Asylia Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Telormedix and ImmunOs Therapeutics AG are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Telormedix, https://bouncewatch.com/company/telormedix, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes